Women Can Now Assess Their Breast Cancer Risk With the Help of A.I.
Clairity Breast, an A.I. tool that can predict five-year risk of developing breast cancer, is rolling out nationwide. Here’s what experts want you to know.
TL;DR
- Everlywell is now offering Clairity Breast nationwide, an AI tool that predicts a woman's five-year risk of breast cancer using a single mammogram.
- The FDA-approved tool provides a percentage score of future risk, intended to be used with other clinical information.
- The test costs $249 and is not covered by insurance.
- Experts believe this technology has the potential to change practices and help detect cancers earlier, especially as younger women are being diagnosed.
- Clairity Breast was previously available only in select locations in Massachusetts and Colorado.